Form 13-F position report

EYEPOINT PHARMACEUTICALS, INC.

Reported by FRED ALGER MANAGEMENT LLC

EYPT CUSIP 30233G209 Manager CIK 0000003520

Reported 69,908 shares, down 2,192 (3.0%) from the prior quarter.

Reported value -37.2%; share count -3.0% vs. the prior quarter.

Reduced
% of reported 13F value < 0.01% This manager · Q2 2022
Shares 69,908 Quarter-end amount reported
Reported value $550,000 Fair value at quarter end
Consecutive quarters held 4 Through Q2 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-09-30 1260000
2021-12-31 2234000
2022-03-31 876000
2022-06-30 550000
2022-09-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

5 quarters
Quarterly reported position history for EYEPOINT PHARMACEUTICALS, INC. held by FRED ALGER MANAGEMENT LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2022 Reduced 0 -69,908 (-100.0%) 0 $0 2022-11-15
Q2 2022 Reduced 69,908 -2,192 (-3.0%) < 0.01% $550,000 2022-08-15
Q1 2022 Reduced 72,100 -110,430 (-60.5%) < 0.01% $876,000 2022-05-16
Q4 2021 Added 182,530 +61,617 (51.0%) < 0.01% $2,234,000 2022-02-14
Q3 2021 New 120,913 +120,913 (0.0%) < 0.01% $1,260,000 2021-11-15

Who else reported the position

87 managers reported EYEPOINT PHARMACEUTICALS, INC. for Q2 2022.

Managers reporting EYEPOINT PHARMACEUTICALS, INC. in Q2 2022.
Manager Activity Shares Change % of reported 13F Reported value Tenure
FRANKLIN RESOURCES INC Added 5,450,253 +130,425 0.02% $42,894,000 7 qtrs
Essex Woodlands Management Inc Unchanged 4,190,921 0 13.63% $32,983,000 7 qtrs
RA CAPITAL MANAGEMENT L P Unchanged 3,370,506 0 0.71% $26,526,000 6 qtrs
SUVRETTA CAPITAL MANAGEMENT LLC Added 2,968,207 +58,800 0.89% $23,360,000 6 qtrs
ADAGE CAPITAL PARTNERS GP L L C Unchanged 1,950,000 0 0.04% $15,347,000 6 qtrs
BlackRock Inc Added 1,568,762 +42,609 < 0.01% $12,347,000 7 qtrs
VANGUARD GROUP INC Added 1,355,318 +122,517 < 0.01% $10,666,000 7 qtrs
Point72 Asset Management L P Added 1,219,699 +186,899 0.04% $9,599,000 2 qtrs
CITADEL ADVISORS LLC Reduced 1,041,017 -429,279 < 0.01% $8,193,000 7 qtrs
JANUS HENDERSON GROUP PLC Reduced 990,036 -512,744 < 0.01% $7,794,000 7 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2022
Filed
August 15, 2022
Filing type
13F-HR
Position type
Common

Voting authority reported

Sole
69,908
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.